Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long‐term response
Miriam Marangon(Istituto Oncologico Romagnolo), Francesco Zaja, Nicola Polverelli(University of Pavia), Elisa Lucchini(Ospedale Santa Maria della Misericordia di Udine), Miriam Isola(University of Udine), Wilma Barcellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Renato Fanin(University of Udine), Nicola Vianelli(Istituto di Ematologia di Bologna), Cristina Santoro(Sapienza University of Rome), Bruno Fattizzo(University of Milan), Monica Carpenedo(University of Milano-Bicocca), Francesca Palandri(Istituto Oncologico Romagnolo), Maria Gabriella Mazzucconi(Sapienza University of Rome), Stefano Volpetti(Ospedale Santa Maria della Misericordia di Udine)
Cited by 90
Related Papers
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
|Blood|2020|657
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
|New England Journal of Medicine|2016|491
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
|Blood|2014|371
Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia
|Disease Markers|2015|281
Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey
|Clinical Microbiology and Infection|2014|241